Compare KOPN & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KOPN | BBNX |
|---|---|---|
| Founded | 1984 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 856.9M | 997.9M |
| IPO Year | 2025 | 2025 |
| Metric | KOPN | BBNX |
|---|---|---|
| Price | $3.59 | $16.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 15 |
| Target Price | $8.43 | ★ $24.24 |
| AVG Volume (30 Days) | ★ 3.1M | 912.1K |
| Earning Date | 11-11-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 103.03 | 78.95 |
| EPS | ★ N/A | N/A |
| Revenue | $1,530,311.00 | ★ $100,251,000.00 |
| Revenue This Year | $54.14 | $25.74 |
| Revenue Next Year | $31.17 | $44.51 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 46.53 | ★ 53.94 |
| 52 Week Low | $1.81 | $8.80 |
| 52 Week High | $6.61 | $32.71 |
| Indicator | KOPN | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 33.83 | 40.96 |
| Support Level | $3.26 | $15.76 |
| Resistance Level | $3.56 | $18.20 |
| Average True Range (ATR) | 0.30 | 0.87 |
| MACD | -0.15 | -0.29 |
| Stochastic Oscillator | 14.56 | 24.84 |
Kopin Corp is a developer and provider of inventive display, and application-specific optical solutions sold as critical components and subassemblies for defense, enterprise, professional and consumer products. Its portfolio includes micro displays, display modules, eyepiece assemblies, image projection modules, and vehicle mounted and head-mounted display systems that incorporate ultra-small high-resolution Active Matrix Liquid Crystal displays (AMLCD), Ferroelectric Liquid Crystal on Silicon (FLCoS) displays, MicroLED displays (uLED) and Organic Light Emitting Diode (OLED) displays, a variety of optics, and low-power ASICs. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.